biomedicina slovenica


"HYPERCHOLESTEROLEMIA" : 230

  1. Santos Raul D.; Ruzza Andrea; Hovingh G. Kees; Wiegman Albert; Mach François; Kurtz Christopher E.; Hamer Andrew; Bridges Ian; Bartuli Andrea; Bergeron Jean; Grošelj Urh
    Evolocumab in pediatric heterozygous familial hypercholesterolemia
    2020
  2. Šuštar Urša; Mlinarič Matej; Kovač Jernej; Sedej Katarina; Jenko Bizjan Barbara; Trebušak Podkrajšek Katarina; Battelino Tadej; Grošelj Urh
    Universal hypercholesterolemia screening in pre-school children
    2022
  3. Šuštar Urša; Mlinarič Matej; Kovač Jernej; Sedej Katarina; Jenko Bizjan Barbara; Trebušak Podkrajšek Katarina; Battelino Tadej; Grošelj Urh
    Nacionalni program populacijskega presejanja na družinsko hiperholesterolemijo pri predšolskih otrocih
    [National population screening program for familial hypercholesterolemia in preschool children]
    2022
  4. Šuštar Urša; Kordonouri Olga; Mlinarič Matej; Kovač Jernej; Arens Stefan; Sedej Katarina; Jenko Bizjan Barbara; Trebušak Podkrajšek Katarina; Danne Thomas; Battelino Tadej; Grošelj Urh
    Universal screening for familial hypercholesterolemia in 2 populations
    2022
  5. Petrič Kristian; Klemenc-Ketiš Zalika; Petek Šter Marija; Petek Davorina
    Pogostost hiperholesterolemije in dejavniki, povezani z njo pri udeležencih preventivnih pregledov v ambulantah družinske medicine v Sloveniji
    2022
  6. Šuštar Urša; Grošelj Urh; Trebušak Podkrajšek Katarina; Mlinarič Matej; Kovač Jernej; Thaler Martin; Drole Torkar Ana; Skarlovnik Ajda; Battelino Tadej; Hovnik Tinka
    Early discovery of children with lysosomal acid lipase deficiency with the Universal Familial Hypercholesterolemia Screening Program
    2022
  7. Pučko Diana; Klemenc-Ketiš Zalika; Selič-Zupančič Polona
    Določanje tveganja za družinsko hiperholesteromijo
    2022
  8. Banerjee Yajnavalka; Pantea Stoian Anca; Cicero Arrigo Francesco Giuseppe; Fogacci Federica; Nikolic Dragana; Sachinidis Alexandros; Rizvi Ali A.; Janež Andrej; Rizzo Manfredi
    Inclisiran
    2021
  9. Pajek Maja; Avbelj Stefanija Magdalena; Trebušak Podkrajšek Katarina; Šuput Jasna; Žerjav-Tanšek Mojca; Battelino Tadej; Grošelj Urh
    Hypercholesterolemia in two siblings with resistance to thyroid hormones due to disease-causing variant in thyroid hormone receptor (THRB) gene
    2020
  10. Blinc Lana; Mlinarič Matej; Battelino Tadej; Grošelj Urh
    High-sensitivity C-reactive protein and carotid intima media thickness as markers of subclinical inflammation and atherosclerosis in pediatric patients with hypercholesterolemia
    2020
  11. Mlinarič Matej; Bratanič Nevenka; Dragoš Vlasta; Skarlovnik Ajda; Cevc Matija; Battelino Tadej; Grošelj Urh
    Case Report
    2020
  12. Sherer Yaniv; Tenenbaum Alexander; Blank Miri; Shemesh Joseph; Harats Dror; Fisman Enrique Z.; Praprotnik Sonja; Motro Michael; Shoenfeld Yehuda
    Autoantibodies to oxidized low-density lipoprotein in coronary artery disease
    2001
  13. Marusic Tatiana; Šuštar Urša; Sadiq Fouzia; Kotori Vjosa; Mlinarič Matej; Kovač Jernej; Cevc Matija; Trebušak Podkrajšek Katarina; Battelino Tadej; Grošelj Urh
    Genetic and clinical characteristics of patients with homozygous and compound heterozygous familial hypercholesterolemia from three different populations
    2020
  14. Banach Maciej; Penson Peter E.; Fras Zlatko; Vrablik Michal; Pella Daniel; Reiner Željko; Nabavi Seyed M.; Sahebkar Amirhossein; Kayikcioglu Meral; Daccord Magdalena
    Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
    2020
  15. Wilemon Katherine A.; Patel Jasmine; Aguilar-Salinas Carlos; Ahmed Catherine D.; Alkhnifsawi Mutaz; Almahmeed Wael; Alonso Rodrigo; Al-Rasadi Khalid; Badimon Lina; Bernal Luz M.; Grošelj Urh
    Reducing the clinical and public health burden of familial hypercholesterolemia
    2020
  16. Banach Maciej; Bruckert Eric; Descamps Olivier; Ellegård Lars; Ezhov Marat; Föger Bernhard; Fras Zlatko; Kovanen Petri T.; Latkovskis Gustavs; März Winifred
    The role of red yeast rice (RYR) supplementation in plasma cholesterol control: a review and expert opinion
    2019
  17. Kovač Urša; Kovač Jernej; Maličev Elvira; Jasper Elizabeth A.; Trebušak Podkrajšek Katarina; Battelino Tadej; Ryckman Kelli K.; Rozman Damjana
    The circadian aspect of PNPLA3 p.I148M and TM6SF2 p.E167K in hypercholesterolemia
    2019
  18. Grošelj Urh; Kovač Jernej; Šuštar Urša; Mlinarič Matej; Fras Zlatko; Trebušak Podkrajšek Katarina; Battelino Tadej
    Universal screening for familial hypercholesterolemia in children
    2018
  19. Ceška R.; Paragh György; Reiner Željko; Banach Maciej; Tokgözoğlu Lale; Susekov Andrey V.; Rašlová Katarína; Freiberger Tomas; Vohnout Branislav; Rynkiewicz Andrzej; Fras Zlatko
    ScreenPro FH - screening project for familial hypercholesterolemia in Central, Southern and Eastern Europe
    2017
  20. Ceška R.; Freiberger Tomas; Susekov Andrey V.; Paragh György; Reiner Željko; Tokgözoğlu Lale; Rašlová Katarína; Banach Maciej; Vohnout Branislav; Rynkiewicz Andrzej; Fras Zlatko
    ScreenPro FH - screening project for familial hypercholesterolemia in Central, Southern and Eastern Europe
    2017
  21. Josipović Božo; Jablanovic D. D. J.; Nedeljkovic R.; Ilic S.
    Unrecognized seropositive RA and SS in a patient with associated familial hypercholesterolemia type IIa and osseous xanthoma of the proximal femur
    2003
  22. Marčun-Varda Nataša; Nikolić Sara; Močnik Mirjam
    Subendocardial viability ratio and ejection duration as parameters of early cardiovascular risk in children
    2017
  23. Anžič Ajda; Grošelj Urh; Skarlovnik Ajda
    Ocenjevanje tveganja za srčno-žilna obolenja pri osebah z družinsko hiperholesterolemijo
    [Cardiovascular risk assessment in individuals with familial hypercholesterolemia]
    2017
  24. Marazzi Giuseppe; Pelliccia Francesco; Campolongo Giuseppe; Cacciotti Luca; Poggi Sara; Tanzilli Alessandra; Di Iorio Martina; Volterrani Maurizio; Lainščak Mitja; Rosano Giuseppe M.
    Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial
    2016
  25. Klančar Gašper; Battelino Tadej; Trebušak Podkrajšek Katarina
    Genetske značilnosti hiperholesterolemij pri otrocih in mladostnikih v Sloveniji
    [Genetic charateristics of hypercholesterolemia in children and adolescents in Slovenia]
    2016
  26. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Matematični model vpliva bolezni in dejavnikov tveganja na razvoj možganske kapi
    2007
  27. Mičetić-Turk Dušanka; Šikić Pogačar Maja; Marčun-Varda Nataša; Dolinšek Jernej; Urlep Žužej Darja
    The impact of overweight and obesity on health-related quality-of-life among children and adolescents in Slovenia
    2008
  28. Obesity, familial hypercholesterolemia
    2008
  29. Klančar Gašper; Grošelj Urh; Kovač Jernej; Bratanič Nevenka; Bratina Nataša; Battelino Tadej; Trebušak Podkrajšek Katarina
    Implementation of next generation sequencing in national universal hypercholesterolemia screening
    2015
  30. Klančar Gašper; Grošelj Urh; Kovač Jernej; Bratanič Nevenka; Bratina Nataša; Trebušak Podkrajšek Katarina; Battelino Tadej
    Universal screening for familial hypercholesterolemia in children
    2015
  31. Klančar Gašper; Trebušak Podkrajšek Katarina
    Opredelitev genskih vzrokov hiperholesterolemij
    [Determination of genetic causes of hypercholesterolemia]
    2014
  32. Klančar Gašper; Grošelj Urh; Bratina Nataša; Bratanič Nevenka; Battelino Tadej; Trebušak Podkrajšek Katarina
    The LDLR gene analysis in the slovene familial hypercholesterolemia (fh) population
    2012
  33. Grošelj Urh; Klančar Gašper; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Some characteristics of the Slovene familial hypercholesterolemia (FH) pediatric population
    2012
  34. Kovač Urša; Košir Rok; Fužir Natalija; Lewinska Monika; Kovač Jernej; Klančar Gašper; Trebušak Podkrajšek Katarina; Kotnik Primož; Battelino Tadej; Rozman Damjana
    PNPLA3 as a potential marker for non-alcoholic fatty liver disease in children with familial hypercholesterolemia?
    2015
  35. Klančar Gašper; Grošelj Urh; Bratina Nataša; Trebušak Podkrajšek Katarina; Battelino Tadej
    LDLR and APOB gene analysis in the Slovene population of the children and adolescents with hypercholesteromia
    2013
  36. Klančar Gašper; Malovrh Petra; Grošelj Urh; Bratanič Nevenka; Bratina Nataša; Božič Mojca; Cevc Matija; Battelino Tadej; Trebušak Podkrajšek Katarina
    Familial defective apolipoprotein B-100
    2014
  37. Klančar Gašper; Grošelj Urh; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Genetic characteristics of hypercholesterolemia in children and adolescents in Slovenia
    2013
  38. Grošelj Urh; Klančar Gašper; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Clinical and genetic characteristics of the paediatric heterozygous familial hypercholesterolaemia population in Slovenia: a preliminary report
    2013
  39. Ponikvar Rafael; Žugić Ratko; Dedić Hasan; Gaber Liljana; Buturović-Ponikvar Jadranka; Kovač Janko; Premru Vladimir; Benedik Miha; Marn-Pernat Andreja; Gubenšek Jakob; Poljančič A; Knap Bojan
    22 years of LDL apheresis in a patient with familial homozigous hypercholesterolemia
    2012
  40. Kusters DM; de Beaufort C; Widhalm K; Guardamagna O; Bratina N; Ose L; Wiegman A
    Paediatric screening for hypercholesterolaemia in Europe
    2012
  41. Poredoš Pavel; Ježovnik Mateja Kaja
    Dyslipidemia, statins, and venous thromboembolism
    2011
  42. Režen Tadeja
    The impact of cholesterol and its metabolites on drug metabolism
    2011
  43. Lunder Mojca; Žiberna Lovro; Drevenšek Gorazd; Šabovič Mišo
    Zaščitni pleiotropni učinki statinov
    [Beneficial pleiotropic effects of statins]
    2011
  44. Tušek-Bunc Ksenija; Kersnik Janko; Petek-Šter Marija; Petek Davorina; Klemenc-Ketiš Zalika
    Explanatory model of prescribing behavior in prescription of statins in family practice
    2010
  45. Pietroleonardo L; Ruzicka T
    Skin manifestations in familial heterozygous hypercholesterolemia
    2009
  46. Premru V; Ponikvar R
    LDL apheresis in two children with homozygous familiar hypercholesterolemia
    2009
  47. Bregar U; Poredoš P; Šabovič M; Jug B; Šebeštjen M
    The influence of atorvastatin on walking performance in peripheral arterial disease
    2009
  48. Kuzman Drago; Fon Tacer Klementina; Černe M; Režen Tadeja; Ačimovič Jure; Čegovnik Urška; Kocjan Darko; Urleb Uroš; Rozman Damjana
    Modulation of hepatic transcriptomein the poloxamer P-407 hyperlipidemia mouse model
    2009
  49. Bregar Urška
    Hemodinamski učinki statinov pri bolnikih s periferno arterijsko boleznijo: magistrsko delo
    2008
  50. Premru V; Ponikvar R
    LDL apheresis in two children with homozygous familiar hypercholesterolemia
    2008
  51. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Modelling of the risk factors and chronic diseases that influence the development of serious health complications
    [Modeliranje dejavnikov tveganja in kroničnih bolezni, ki vplivajo na razvoj hujših zdravstvenih zapletov]
    2008
  52. Barbič-Žagar Breda; Kos Jernej; Grošelj Mateja
    Klinične izkušnje z atorvastatinom v visokih odmerkih
    [Clinical experience with high doses of atorvastatin]
    2007
  53. Kohalmy Krisztina; Rozman Damjana; Pascussi Jean-Marc; Sarvary Eniko; Monostory Katalin
    A koleszterinhomeosztazis es a gyogyszer-metabolizmus kapcsolata
    [Crosstalk between cholesterol homeostasis and drug metabolism]
    2008
  54. Pregelj Peter
    Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins
    2008
  55. Vrtovec B; Okrajšek R; Goličnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure
    2008
  56. Poredoš P
    Secondary prevention of peripheral arterial disease with drugs
    2007
  57. Nicholls Stephen J; Tuzcu E Murat; Sipahi Ilke; Grasso Adam W; Schoenhagen Paul; Hu Tingfei; Wolski Kathy; Crowe Tim; Desai Milind Y; Hazen Stanley L
    Statini, holesterol v lipoproteinih velike gostote in regresija koronarne ateroskleroze
    [Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis]
    2007
  58. Fras Zlatko
    Je mogoče s statini zavreti ali celo (o)zdraviti aterosklerozo?
    2007
  59. Kenda Miran F.; Fras Zlatko
    25. Radenski dnevi. Program in zbornik prispevkov: jubilejno tradicionalno letno strokovno srečanje Združenja kardiologov Slovenije; 2007 maj 24-26; Radenci
    2007
  60. Lainščak Mitja; von Haehling Stephan; Springer Jochen; Anker Stefan D
    Biomarkers for chronic heart failure
    2007
  61. Fras Zlatko
    Preventivni ukrepi in zdravljenje dislipidemij pri bolniku po prebolelem srčnem infarktu
    2007
  62. Bulc Mateja
    Why men?
    2001
  63. Bedernjak-Bajuk Nataša
    Sladkorna bolezen - tveganje za nastanek akutnega infarkta srca
    2000
  64. Žemva Aleš; Benca Maja
    From endothelial dysfunction to hypertension
    [Od endotelijske disfunkcije do hipertenzije]
    2006
  65. Gomez MI; Perez B; Contreras JA; de Las Heras MH; Rocamora A; Ledo A
    Xanthoma disseminatum associated with hypocholesterolemia and hypolipoproteinemia
    1994
  66. Del Rio M; Chulia T; Merchan-Perez A; Remezal M; Valor S; Gonzalez J; Gutierrez JA; Contreras JA; Lasuncion MA; Tejerina T
    Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits
    1995
  67. Eržen Barbara; Gradišek Primož; Poredoš Pavel; Šabovič Mišo
    Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries
    2006
  68. Dajčman Davorin
    Bolnik z mešano hiperlipidemijo, periferno okluzivno arterijsko boleznijo in prsno bolečino - prikaz primera
    [Patient with mixed hyperlipidemia, peripheral occlusive arterial disease and chest pain - case report]
    2006
  69. Završnik Matej
    Motnje v presnovi maščob
    [Dyslipidemia]
    2006
  70. Lainščak Mitja; Fras Zlatko
    Ali je nefarmakološka obravnava hiperholesterolemije lahko učinkovita? Rezultati raziskave Becel Pro.Activ v Sloveniji
    2006
  71. Cevc Matija
    Farmakoekonomika zdravljenja dislipedemij pri bolnikih z akutnim koronarnim sindromom
    [Pharmacoeconomics of dyslipidemia treatment in patients with acute coronary syndrome]
    2006
  72. Fras Zlatko
    Učinkovitost kombiniranega zdravljenja hiperholesterolemije s statini in ezetimibom - prikaz rezultatov raziskave SI-SPECT
    [Effectiveness of combined statin plus ezetimibe treatment of hypercholesterolemia - presentation of SI-SPECT programme results]
    2006
  73. Lainščak Mitja; Fras Zlatko
    Nefarmakološki ukrepi ob hiperholesterolemiji - ali imamo nove možnosti?
    2006
  74. Šabovič Mišo
    Zdravljenje stabilne angine pektoris s statini
    2006
  75. Binbrek Azan S; Elis Avishay; Al-Zaibag Muayed; Eha Jaan; Keber Irena; Cuevas Ada M; Mukherjee Swati; Miller Thomas R
    Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: a randomized, open-label, parallel-group, multicenter study (DISCOVERY alpha study)
    2006
  76. Fras Zlatko
    Kako obravnavamo dislipidemije v Sloveniji?
    2006
  77. Cevc Matija
    Farmakoekonomske osnove zdravljenja dislipidemij
    2006
  78. Černe Andreja
    Maščobe v krvi
    2005
  79. Fras Zlatko
    Obravnava dislipidemije pri metaboličnem sindromu
    2005
  80. Bešlić Šerif; Dalagija Faruk
    Coronary artery calcium scoring in myocardial infarction
    [Ugotavljanje koronarne kalcifikacije pri miokardnem infarktu]
    2005
  81. Štubler Mira
    Zdravstvena nega po operaciji in svetovanje glede zdravega načina življenja
    2005
  82. Černe Andreja; Kranjec Igor; Peterlin Borut
    Angiotensin-converting enzyme gene polymorphism and acute coronary syndrome
    [Polimorfizmi gena za encim angiotenzinsko konvertazo pri bolnikih z akutnim koronarnim sindromom]
    2005
  83. Medvešček Marko
    Sladkorna bolezen tipa 2 - pandemija 21. stoletja
    2004
  84. Tasič Janez
    Zniževanje holesterola - dieta namesto zdravil!
    2003
  85. Hlastan-Ribič Cirila
    Tudi rastlinske maščobe so lahko škodljive
    2003
  86. Uršič-Bratina Nataša; Bratanič Nina; Battelino Tadej
    Nevarne povišane maščobe v krvi otroka
    2003
  87. Blinc Aleš
    Sistematično izmišljanje novih bolezni?
    2003
  88. Bombek Mirko
    Koliko smo naredili za preprečevanje bolezni srca in ožilja?
    2002
  89. Pavčič Maruša
    S fitosteroli nad holesterol
    2001
  90. Cevc Matija
    Povišana raven holesterola v krvi v poznejših letih
    2005
  91. Bratanič Nevenka; Vesel Samo; Uršič-Bratina Nataša; Žerjav-Tanšek Mojca; Sedmak Marjeta; Kržišnik Ciril; Battelino Tadej
    Familiarna hiperholesterolemija
    2005
  92. Šebeštjen Miran
    Novi dejavniki tveganja za aterosklerozo: pomen in možnosti zdravljenja
    2005
  93. Pintar Tatjana
    Vpliv statinov na pooperativne zaplete pri bolnikih po kirurški revaskularizaciji venčnih arterij
    2005
  94. Grad Anton; Žvan Bojana
    Možganska kap v Sloveniji upada
    2001
  95. Rotovnik-Kozjek Nada
    Prehrana, gibanje in zdravje
    2005
  96. Zaletel-Kragelj Lijana; Fras Zlatko
    Stanje gibanja za zdravje pri odraslih prebivalcih v Sloveniji. Rezultati skupne raziskave CINDI Slovenije in projekta CRP Gibalna/športna aktivnost za zdravje
    2005
  97. Goličnik Alenka; Ferjan Mateja
    Vpliv atorvastatina na trajanje intervala QTC pri bolnikih s srčnim popuščanjem
    2004
  98. Tomažič Janez; Silič Anja; Karner Primož; Vidmar Ludvik; Matičič Mojca; Poljak Mario; Ihan Alojz; Janež Andrej
    Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients
    2004
  99. Poredoš Pavel
    Involvement of endothelial dysfunction in atherogenesis
    2004
  100. Poredoš Pavel; Blinc Aleš
    What is new in angiology?
    2005

1 101 201  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko